Results 131 to 140 of about 73,761 (306)
Leishmaniasis in Patients With Inflammatory Bowel Disease: A National Multicenter Study of GETECCU
United European Gastroenterology Journal, EarlyView.ABSTRACT Background
Leishmaniasis (LI) is a vector‐borne illness caused by a protozoan of the genus Leishmania. Data on the features of LI in patients with inflammatory bowel disease (IBD) are scarce. Aim
To describe the characteristics of patients with IBD who present with leishmaniasis, infection outcomes and the risk factors associated with ...L Madero‐Velázquez, A Mínguez, L Mayorga, JJ Ramírez, N Moreno, C Amorós, MA Nieto, R Mena, JM Benítez, L Gimeno‐Pitarch, N Maroto, C Suria, F Rodríguez‐Moranta, I Ordás, L Ruiz, MA García‐Brenes, A Martín‐Cardona, C Rubín de Célix, K Cárdenas, D Ginard, L Medina, N Pedrero, R Plaza, R Salmoral, TJ Martínez‐Pérez, V Algara, E Merino, Y Zabana, A Gutiérrez, on behalf of Young Group of GETECCU +29 morewiley +1 more sourceRole of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
European Journal of Neurology, Volume 30, Issue 1, Page 266-282, January 2023., 2023 Myasthenia gravis is recognized as an immunoglobulin G autoantibody‐mediated disease, but the relationship between autoantibody levels and disease activity is unclear. We conducted a systematic literature review to evaluate this landscape, which yielded 10 studies mainly describing a positive, significant correlation.Andreas Meisel, Fulvio Baggi, Anthony Behin, Amelia Evoli, Anna Kostera‐Pruszczyk, Renato Mantegazza, Raul Juntas Morales, Anna Rostedt Punga, Sabrina Sacconi, Michael Schroeter, Jan Verschuuren, Louise Crathorne, Kris Holmes, Maria‐Isabel Leite +13 morewiley +1 more sourceFactors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
European Journal of Neurology, Volume 30, Issue 2, Page 399-412, February 2023., 2023 Abstract Background and purpose
Clinical outcome information on patients with neuromuscular diseases (NMDs) who have been infected with SARS‐CoV‐2 is limited. The aim of this study was to determine factors associated with the severity of COVID‐19 outcomes in people with NMDs.Chiara Pizzamiglio, Robert D. S. Pitceathly, Michael P. Lunn, Stefen Brady, Fabiola De Marchi, Lucia Galan, Jeannine M. Heckmann, Alejandro Horga, Maria J. Molnar, Acary S. B. Oliveira, Wladimir B. V. R. Pinto, Guido Primiano, Ernestina Santos, Benedikt Schoser, Serenella Servidei, Paulo V. Sgobbi Souza, Vishnu Venugopalan, Michael G. Hanna, Mazen M. Dimachkie, Pedro M. Machado, for the Neuromuscular Diseases and COVID‐19 Study Group, Albert Lim, Amar Elsaddig, Ana Juanatey, Ana Romeiro, Andreas Themistocleous, Annamaria Kiss‐Csenki, Antonio Guerrero Sola, Anuja Patil, Ashish Duggal, Carolyn Gabriel, Charles Marshall, Christopher Record, Claire Allen, David Bearden, DeviPriya Rathna Sabapathi, Dileep R, Domizia Vecchio, Edward Newman, Edwin Eshun, Eng C. Foo, Enrico Bugiardini, Georgina Burke, Gita Ramdharry, Gràinne S. Gorman, Guru Kumar, Harri Sivasathiaseelan, Igor Braga Farias, Izelle Smuts, James Holt, Jan T. Groothuis, Jane Pritchard, Jasmine Wall, Josep Gamez, K. J. S. Shakthi, Kate Wannop, Kathryn Brennan, Lillian Saavedra, Lisa Clayton, Liz Househam, Mariola Skorupinska, Matilde Laura, Matteo Ciocca, Maya Zosmer, Megha Dhamne, Michelangelo Mancuso, Mirian Janssen, Olimpia Musumeci, Olivia Price, Patrick F. Chinnery, Philip Ambrose, Puja R. Mehta, Rhys H. Thomas, Rita Horvath, Robert McFarland, Ross Nortley, Ross W. Paterson, Ruth Geraldes, Ryan Keh, Saara Neshuku, Sandhya Sasidharan, Sarath Menon R, Sharika Raga, Simon Rinaldi, Sireesha Yareeda, Soaham Desai, Sridharan Ramaratnam, Stephen Keddie, Taylor Watson‐Fargie, Teresinha Evangelista, Valeria Sansone, Victoria Nesbitt, William L. Macken, Yavuz Oktay +93 morewiley +1 more sourceEFFECTS OF TACROLIMUS ON HYPERLIPIDEMIA AFTER SUCCESSFUL RENAL TRANSPLANTATION
, 1998 Thomas R. McCune, Leroy R. Thacker, Thomas G. Peters, Laura Mulloy, Michael S. Rohr, Patricia A. Adams, Jackson Joe Yium, Jimmy A. Light, Timothy L. Pruett, A. Osama Gaber, Steven H. Selman, Johann Jonsson, Joseph M. Hayes, Francis H. Wright, Thomas A. Armata, Jack Blanton, James F. Burdick +16 moreopenalex +1 more sourceA prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up [PDF]
, 1999 R Shapiro, Mark L. Jordan, Velma P. Scantlebury, Carlos Vivas, J. Wallis Marsh, J McCauley, James R. Johnston, Parmjeet Randhawa, William Irish, H. Albin Gritsch, Ramin Naraghi, T.R. Hakala, John J. Fung, Thomas E. Starzl +13 moreopenalex +1 more sourceREVERSAL OF EARLY ACUTE REJECTION WITH INCREASED DOSES OF TACROLIMUS IN LIVER TRANSPLANTATION
, 1998 Olivier Boillot, Jean–Paul Viale, P Gratadour, Pierre Méeus, Pierre Souraty, Y Le Derf, Isabelle Méchet, Jean‐Yves Scoazec, Francoise Berger, P Paliard +9 moreopenalex +1 more sourceTacrolimus nephrotoxicity after renal transplantation [PDF]
, 1997 Sunita Katari, Mario Magnone, Ron Shapiro, Mark L. Jordan, Velma P. Scantlebury, Carlos Vivas, H. Albin Gritsch, J McCauley, TE Starzl, Anthony J. Demetris, Parmjeet Randhawa +10 moreopenalex +1 more source
